Stockscreener 앱 받기
2.06
0.98%
0.02
Seastar Medical Holding Corp 주식(ICU)의 최신 뉴스
SEASTAR ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
ICU stock hits 52-week low at $1.82 amid market challenges - Investing.com
Medical Device Co. Brass Hid SPAC's True Value, Suit Says - Law360
SeaStar Medical Projects Multibillion-Dollar Market - GlobeNewswire
SeaStar Medical to Hold Business Update Conference Call on December 11, 2024 - GlobeNewswire
SeaStar Medical (ICU) to Host Key Business Update Call on December 11 - StockTitan
SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial - GlobeNewswire
SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune - Investing.com Nigeria
SeaStar Medical (NASDAQ:ICU) Trading Down 1.6% – What’s Next? - Defense World
SeaStar Medical reduces authorized shares By Investing.com - Investing.com Canada
SeaStar Medical reduces authorized shares - Investing.com
SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024 - GlobeNewswire
SeaStar Medical to Present at NobleCon20 Conference on Hyperinflammation Solutions | ICU Stock News - StockTitan
Leading Independent Proxy Advisory Firms ISS and Glass - GlobeNewswire
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares - Quantisnow
SeaStar Medical chief medical officer purchases $8,457 in stock By Investing.com - Investing.com Australia
SeaStar Medical chief medical officer purchases $8,457 in stock - Investing.com
Seastar Soars On Latest Tidings - MENAFN.COM
SeaStar Soars on Latest Tidings - Baystreet.ca
SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer - Yahoo Finance
SeaStar Medical reports net revenue of USD 67,500 in Q3 2024 - Medical Buyer
SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update - Yahoo Finance
Half of Patients Now Enrolled in SeaStar Medical’s NEUTRALIZE-AKI Trial - MPO-mag
Critical Analysis: Merit Medical Systems (NASDAQ:MMSI) and SeaStar Medical (NASDAQ:ICU) - Defense World
SeaStar Medical (NASDAQ:ICU) Trading Down 3% – Here’s What Happened - Defense World
FDA grants breakthrough status to SeaStar Medical's SCD - Investing.com
FDA Grants Breakthrough Device Designation for SeaStar - GlobeNewswire
FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis - Yahoo Finance
Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial - GlobeNewswire
SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE - Yahoo Finance
ICUSeaStar Medical Holding Corporation Latest Stock News & Market Updates - StockTitan
Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024Update - Yahoo Finance
SeaStar Medical Announces that Stanford Medicine is Cleared - GlobeNewswire
Nuwellis ends SeaStar distribution and supply agreements - Investing.com
Seastar Medical settles dispute with Nuwellis for $900K - Investing.com
Seastar Medical settles dispute with Nuwellis for $900K By Investing.com - Investing.com UK
SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers - GlobeNewswire
SeaStar Medical's NEUTRALIZE-AKI trial surpasses halfway mark - Investing.com
SeaStar Medical's NEUTRALIZE-AKI trial surpasses halfway mark By Investing.com - Investing.com South Africa
SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis - GlobeNewswire
SeaStar Medical to Showcase New Mechanistic Data - GlobeNewswire
SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit - GlobeNewswire
SeaStar Medical expands trial sites for kidney injury device - Investing.com
SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities - GlobeNewswire
SeaStar medical executive buys $4.3k in company stock By Investing.com - Investing.com Australia
SeaStar medical executive buys $4.3k in company stock - Investing.com
SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial - GlobeNewswire
2.88%
2.65%
자본화:
|
볼륨(24시간):